Preventive Efficacy of Tenofovir/Emtricitabine Against Severe Acute Respiratory Syndrome Coronavirus 2 Among Pre-Exposure Prophylaxis Users

BACKGROUND: The preventive effect that tenofovir/emtricitabine (FTC) could have against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human immunodeficiency virus-negative people is unknown. The objective of this study was to analyze the seroprevalence and clinical manifestations o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Open Forum Infect Dis
Päätekijät: Ayerdi, Oskar, Puerta, Teresa, Clavo, Petunia, Vera, Mar, Ballesteros, Juan, Fuentes, Manuel Enrique, Estrada, Vicente, Rodríguez, Carmen, Del Romero, Jorge
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Major Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7543639/
https://ncbi.nlm.nih.gov/pubmed/33200081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa455
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia